Stuttgart - Delayed Quote EUR

Abbott Laboratories (ABL.SG)

Compare
110.38
+0.48
+(0.44%)
At close: January 17 at 4:53:05 PM GMT+1
All numbers in thousands
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
8,728,000.00
7,261,000.00
9,581,000.00
10,533,000.00
7,901,000.00
Investing Cash Flow
-2,296,000.00
-3,133,000.00
-1,740,000.00
-2,008,000.00
-2,215,000.00
Financing Cash Flow
-5,595,000.00
-7,091,000.00
-7,636,000.00
-5,494,000.00
-2,779,000.00
End Cash Position
7,546,000.00
6,896,000.00
9,882,000.00
9,799,000.00
6,838,000.00
Income Tax Paid Supplemental Data
--
1,475,000.00
1,864,000.00
1,941,000.00
970,000.00
Interest Paid Supplemental Data
--
662,000.00
563,000.00
544,000.00
549,000.00
Capital Expenditure
-2,242,000.00
-2,202,000.00
-1,777,000.00
-1,885,000.00
-2,177,000.00
Issuance of Debt
223,000.00
2,000.00
7,000.00
4,000.00
1,281,000.00
Repayment of Debt
-1,071,000.00
-2,498,000.00
-753,000.00
-48,000.00
-1,333,000.00
Repurchase of Capital Stock
-1,239,000.00
-1,227,000.00
-3,795,000.00
-2,299,000.00
-403,000.00
Free Cash Flow
6,486,000.00
5,059,000.00
7,804,000.00
8,648,000.00
5,724,000.00
12/31/2020 - 12/28/2007

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers